Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of Aldosterone Secretion by Substance P and the Neurokinin Type 1 Receptor in Aldosterone-Producing Adenomas.

Journal of the American Heart Association·2026
Same author

Adrenal-adipose tissue crosstalk in health and disease.

European journal of endocrinology·2025
Same author

Real-World Osilodrostat Effectiveness and Safety in Nonpituitary Cushing Syndrome.

The Journal of clinical endocrinology and metabolism·2025
Same author

A Recurrent Splice Variant Sheds Light on 11β-Hydroxylase Deficiency in a Unique Large Cohort.

The Journal of clinical endocrinology and metabolism·2025
Same author

Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trial.

The lancet. Diabetes & endocrinology·2025
Same author

Powder Self-Emulsifying Drug Delivery System for Mitotane: In Vitro and In Vivo Evaluation.

Pharmaceutics·2024
Same journal

[18F]F-DOPA and [18F]F-FDG PET/CT for staging advanced medullary thyroid cancer.

Annales d'endocrinologie·2026
Same journal

Corrigendum to 'Pink adipose tissue: A paradigm of adipose tissue plasticity' [Ann. Endocrinol. 85 (2004) 248-51].

Annales d'endocrinologie·2026
Same journal

Intraoperative location of parathyroid glands during total thyroidectomy: a systematic review of the literature according to the PRISMA method.

Annales d'endocrinologie·2026
Same journal

Clinical and genetic diagnosis of PHP1A associated with hypogonadism in a young male: A case report.

Annales d'endocrinologie·2026
Same journal

Autoimmune features in acquired generalized lipodystrophy and anti-perilipin 1 antibodies: A case report.

Annales d'endocrinologie·2026
Same journal

The diagnostic challenge of occult glucocorticoid exposure causing Cushing's syndrome.

Annales d'endocrinologie·2026
See all related articles

Related Experiment Video

Updated: May 23, 2026

Cortisol Measurement in Koala (Phascolarctos cinereus) Fur
09:11

Cortisol Measurement in Koala (Phascolarctos cinereus) Fur

Published on: August 23, 2019

Corticotroph deficiency.

Hervé Lefebvre1

  • 1Service d'endocrinologie, diabète et maladies métaboliques, Inserm U, institut de recherche et d'innovation biomédicale, université, CHU de Rouen, France. herve.lefebvre@chu-rouen.fr

Annales D'Endocrinologie
|April 21, 2012
PubMed
Summary
This summary is machine-generated.

Diagnosing corticotroph deficiency, or ACTH deficiency, can be challenging. New diagnostic and treatment strategies are needed to accurately assess and manage this condition, improving patient outcomes.

More Related Videos

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

Related Experiment Videos

Last Updated: May 23, 2026

Cortisol Measurement in Koala (Phascolarctos cinereus) Fur
09:11

Cortisol Measurement in Koala (Phascolarctos cinereus) Fur

Published on: August 23, 2019

A Novel Method: Super-selective Adrenal Venous Sampling
06:08

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

Area of Science:

  • Endocrinology
  • Pituitary Disorders
  • Hormone Replacement Therapy

Background:

  • Corticotroph deficiency, or ACTH deficiency, often stems from exogenous glucocorticoid use or hypothalamic-pituitary damage.
  • Diagnosing partial ACTH deficiency is complex, necessitating specialized stimulation tests to evaluate the hypothalamic-pituitary-adrenal axis.
  • Current diagnostic methods like the insulin tolerance test have limitations, while alternatives like metyrapone and cosyntropin tests lack optimal sensitivity.

Purpose of the Study:

  • To review the diagnostic challenges associated with corticotroph deficiency.
  • To explore current and alternative testing modalities for assessing ACTH secretion.
  • To discuss current approaches and limitations in cortisol replacement therapy for corticotroph deficiency.

Main Methods:

  • Review of diagnostic tests for corticotroph deficiency, including stimulation tests (insulin tolerance test, metyrapone, cosyntropin) and basal plasma dehydroepiandrosterone sulfate measurement.
  • Discussion of current cortisol replacement strategies using hydrocortisone.
  • Analysis of the limitations of existing diagnostic and therapeutic approaches.

Main Results:

  • The insulin tolerance test is the gold standard but has contraindications.
  • Metyrapone and cosyntropin tests are alternatives but have suboptimal sensitivity.
  • Normal dehydroepiandrosterone sulfate levels may help exclude corticotroph deficiency.
  • Current hydrocortisone regimens fail to replicate the natural nycthemeral cortisol rhythm.

Conclusions:

  • Accurate diagnosis of corticotroph deficiency remains challenging, particularly in partial cases.
  • Improved diagnostic tools with higher sensitivity and broader applicability are needed.
  • Current cortisol replacement therapy requires optimization to better mimic physiological cortisol secretion patterns.